<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235742</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32212</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet B Neuropsychiatr Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. B Neuropsychiatr. Genet.</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4841</issn>
<issn pub-type="epub">1552-485X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27615674</article-id>
<article-id pub-id-type="pmc">6907071</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.b.32496</article-id>
<article-id pub-id-type="manuscript">NIHMS1036377</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Psychiatric Disorders Among Women With the Fragile X Premutation Without Children Affected by Fragile X Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gossett</surname>
<given-names>Amy</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sansone</surname>
<given-names>Stephanie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schneider</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Johnston</surname>
<given-names>Cindy</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagerman</surname>
<given-names>Randi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tassone</surname>
<given-names>Flora</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rivera</surname>
<given-names>Susan M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Seritan</surname>
<given-names>Andreea L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hessl</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis Medical Center, Sacramento, California</aff>
<aff id="A2"><label>2</label>Department of Psychology, California School of Professional Psychology, Alliant International University, Sacramento, California</aff>
<aff id="A3"><label>3</label>Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, California</aff>
<aff id="A4"><label>4</label>Department of Pediatrics, University of California Davis School of Medicine, Sacramento, California</aff>
<aff id="A5"><label>5</label>Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, California</aff>
<aff id="A6"><label>6</label>Department of Psychology, University of California Davis, Davis, California</aff>
<aff id="A7"><label>7</label>Center for Mind and Brain, University of California Davis, Davis, California</aff>
<author-notes>
<fn fn-type="other" id="FN1">
<p id="P1">Amy Gossett is now in the Department of Psychiatry, Kaiser Permanente, Roseville, California.</p>
</fn>
<fn fn-type="other" id="FN2">
<p id="P2">Dr. Andreea L. Seritan is now in the Department of Psychiatry, University of California San Francisco, and UCSF Weill Institute for Neurosciences, San Francisco, California.</p>
</fn>
<corresp id="CR1"><label>*</label>Correspondence to: David Hessl, Ph.D., Department of Psychiatry and Behavioral Sciences, MIND Institute, UC Davis, 2825 50th St., Sacramento, CA 95817. <email>drhessl@ucdavis.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>3</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>12</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>171</volume>
<issue>8</issue>
<fpage>1139</fpage>
<lpage>1147</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.b.32496-->
<abstract id="ABS1">
<p id="P3">Several studies have demonstrated increased rates of anxiety and depressive disorders among female carriers of the fragile X premutation. However, the majority of these studies focused on mothers of children with fragile X syndrome, who experience higher rates of parenting stress that may contribute to the emergence of these disorders. The present study compared psychiatric symptom presentation (utilizing measures of current symptoms and lifetime DSM-IV Axis I disorders) in 24 female carriers without affected children (mean age = 32.1 years) to 26 non-carrier women from the community (mean age = 30.5years). We also examined the association between CGG repeat size (adjusted for X activation ratio) and mRNA, with severity of psychiatric symptoms. Women with the premutation reported significantly elevated symptoms of anxiety, depression, interpersonal sensitivity, obsessive-compulsiveness, and somatization relative to controls during the past week. Carriers had significantly higher rates of lifetime social phobia (42.3%) compared to controls (12.5%); however, this comparison did not remain significant after multiple comparison adjustment. Rates of other psychiatric disorders were not significantly elevated relative to controls, though it should be noted that lifetime rates among controls were much higher than previously published population estimates. Although the sample is relatively small, the study of this unique cohort suggests the premutation confers risk for mood and anxiety disorders independent of the stress of parenting children with FXS. Screening for psychiatric disorders in women with the premutation, even before they become parents, is important and highly encouraged.</p>
</abstract>
<kwd-group>
<kwd>anxiety</kwd>
<kwd>depression</kwd>
<kwd>social phobia</kwd>
<kwd><italic>FMR1</italic> gene</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>